US Patent Issued to Satsuma Pharmaceuticals on April 7 for "Intranasal DHE for the treatment of headache" (Japanese, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,273, issued on April 7, was assigned to Satsuma Pharmaceuticals Inc..

"Intranasal DHE for the treatment of headache" was invented by Shunji Haruta (Kagoshima-ken, Japan), Nikhilesh N. Singh (Mill Valley, Calif.), John Kollins (San Francisco) and Salvador Rico (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Presented herein are powder formulations comprising dihydroergotamine (DHE), or a pharmaceutically acceptable salt thereof. In addition to such formulations, also presented herein are methods comprising intranasally administering powder formulations comprising dihydroergotamine, or a pharmaceutically acceptable salt thereof. The p...